Together, the data support the conclusion that Bcl-x does not have a central role in modulating tumor apoptosis in this pathway, and that its function is either non-essential, redundant, and/or readily compensated for by other genes, such as other anti-apoptotic members of Bcl-2 family. This evidence concerns the gene BCL2 and neoplasm.